急性腎障害治療市場- 成長、将来展望、競合分析、2024年～2032年

急性腎障害治療市場は、さまざまな促進要因や細分化された側面の影響を受け、2024年から2032年の予測期間中にCAGR 7.8％で成長すると予測されます。市場成長を促進する3つの主要要因は、急性腎障害の有病率の増加、治療方法の進歩、老年人口の増加などです。これらの要因は、効果的なAKI治療に対する需要の急増が予測される、市場の前向きな見通しに寄与しています。競合動向は、Fresenius Medical Care AG &Co.KGaA、Baxter International Inc.研究開発、パートナーシップ、技術統合を含む戦略的イニシアチブは、活気に満ちた進化する市場を裏付けています。これらの企業は、課題に対処し、新たな機会を活用するために戦略的な位置づけを行い、急性腎障害治療市場の将来の軌道を形成しています。

市場促進要因

透析技術の進歩

急性腎障害治療市場の透析分野は、透析技術の継続的な進歩により、大幅な成長を遂げています。2023年には、より効率的で患者に優しい透析方法に対する需要が急増しました。ウェアラブル透析装置やポータブル透析装置などの技術革新が普及し、治療へのアクセスが向上し、AKI患者のQOLが改善されました。先進的な透析技術の採用と患者満足度の向上との間には、正の相関関係があることが実証されています。

支持療法への注目の高まり

支持療法は、包括的な患者管理の必要性に応え、急性腎障害治療市場の極めて重要な促進要因として浮上しました。従来の医療介入を超えた全人的な患者ケアへのパラダイムシフトが、支持療法の隆盛に寄与しました。2023年には、AKI患者の転帰改善における心理社会的支援、栄養介入、症状管理の重要性が認識されつつあることを示すエビデンスが示されました。支持療法戦略は、患者の幸福度を高めるだけでなく、費用対効果の可能性も示しました。

AKIタイプ別セグメンテーション

腎前性AKI、本態性腎AKI、腎後性AKIなど、AKIのタイプに基づく市場セグメンテーションは、治療アプローチの調整において極めて重要な役割を果たしました。2023年には、腎臓への血流低下につながる病態の蔓延を反映して、腎前性AKIセグメントで最も高い収益が観察されました。一方、本態性腎性AKIセグメントは予測期間中に最も高いCAGRを示したが、これは本態性腎問題に対する認識の高まりと的を絞った介入を意味します。

AKI後の回復における課題

急性期治療法の進歩は注目に値するが、市場はAKI後の回復に関して大きな抑制要因に直面しています。2023年には、AKI後の一部の患者において、完全回復の達成と慢性腎臓病の進行予防の成功は限定的であるとのエビデンスが示されました。急性期の治療効果にもかかわらず、長期的な影響と持続的な回復は依然として懸念事項であり、ヘルスケアプロバイダーと患者の双方にとって課題となっています。

治療別の市場透析療法が市場を独占

市場は主に透析療法と支持療法に区分されます。2023年には、透析療法が支配的な治療手段として台頭し、2024年から2032年の予測期間中、最も高い収益を獲得し、最も高い年間平均成長率（CAGR）を示しました。血液透析や腹膜透析を含む透析療法は、AKIに伴う合併症に対処する上で重要な役割を果たし、患者に重要なライフラインを提供しています。

タイプ別市場：腎前性AKIセグメントが市場を独占

AKIは、腎前性AKI、本態性腎AKI、腎後性AKIなど、さまざまなタイプに分類されます。腎前性AKIは、脱水や心不全など、腎臓への血流低下につながる病態の蔓延を示し、2023年に最も高い売上高を記録しました。同時に、本態性腎性AKI分野は予測期間中に最も高いCAGRを示しました。これは、急性尿細管壊死などの本態性腎問題に対する認知度の高まりと的を絞った介入を強調しています。

エンドユーザー別市場：病院が市場を独占

エンドユーザー別セグメンテーションには、病院、外来手術センター（ASC）、その他の医療環境が含まれます。2023年には、収益とCAGRの両面で病院が主要エンドユーザーに浮上しました。病院は、腎障害の急性症例を管理し、専門的なケアを提供し、高度な治療法を利用する上で極めて重要です。外来手術センターやその他のヘルスケア施設も特定のシナリオにおいて重要な役割を果たし、AKI治療の全体的な展望に貢献しています。

北米は依然として世界のリーダーである

地域別セグメント分析では、AKI有病率、ヘルスケアインフラ、治療アクセスの地域差を反映した魅力的な動向が明らかになった。急性腎障害治療市場では、アジア太平洋地域が最も高いCAGRを示しました。この成長は、認知度の向上、ヘルスケアインフラの改善、AKIにつながる疾患の有病率の高さに起因しています。この地域のヘルスケア環境はダイナミックであるため、AKI治療の将来において重要な役割を果たすと考えられます。売上高比率では、北米が2023年の市場をリードしています。この地域の優位性は、患者数の多さ、確立されたヘルスケア施設、AKI管理への積極的なアプローチなどの要因によって後押しされています。地域のニュアンスを理解することは、新たな機会を活用し、多様なヘルスケアエコシステムにおける特定の課題に対処することを目指す利害関係者にとって極めて重要です。

市場競争は予測期間中に激化へ

2023年、急性腎障害治療市場は、Fresenius Medical Care AG &Co.KGaA、Baxter International Inc.、B. Braun Melsungen AG、Angion Biomedica Corp.、AM-Pharma、Quark Pharmaceuticals, Inc.、旭化成メディカル、LG Chemなどです。これらの業界大手は、研究開発、提携、地理的拡大などのイニシアチブを戦略的に実施し、市場での地位を強化しています。特筆すべきは、Fresenius Medical Care AG &Co.KGaAは最先端技術を重視し、バクスター・インターナショナルは患者中心のアプローチを重視しました。さらに、B. Braun Melsungen AGは、M&Aや品質改善などの戦略的イニシアティブを通じて市場力学に大きく貢献しました。このことは、市場情勢が活気に満ちており、競合情勢が進化していることを浮き彫りにしています。

本レポートでお答えする主な質問

急性腎障害治療市場の成長に影響を与えている主要なミクロおよびマクロ環境要因は何か？

現在および予測期間中の製品セグメントと地域に関する主な投資ポケットは？

2032年までの推定推計・市場予測

予測期間中に最も速いCAGRを占めるセグメントは？

市場シェアの大きいセグメントとその理由は？

中低所得国は急性腎障害治療市場に投資しているか？

急性腎障害治療市場で最大の地域市場はどこか？

アジア太平洋、ラテンアメリカ、中東・アフリカなどの新興市場における市場動向と力学は？

急性腎障害治療市場の成長を促進する主要動向は？

世界の急性腎障害治療市場で存在感を高めるための主要な競合企業とその主要戦略とは？

目次

第1章 序文

• レポート内容
  • レポートの目的
  • 対象者
  • 主な提供
• 市場セグメンテーション
• 調査手法
  • フェーズⅠ-二次調査
  • フェーズⅡ-一次調査
  • フェーズⅢ-有識者レビュー
  • 前提条件
  • 採用したアプローチ

第2章 エグゼクティブサマリー

第3章 急性腎障害治療市場：競合分析

• 主要ベンダーの市場ポジショニング
• ベンダーが採用する戦略
• 主要な産業戦略
• ティア分析：2023 vs 2032

第4章 急性腎障害治療市場：マクロ分析と市場力学

• イントロダクション
• 世界の急性腎障害治療市場金額 2022-2032
• 市場力学
  • 市場促進要因
  • 市場抑制要因
  • 主な課題
  • 主な機会
• 促進要因と抑制要因の影響分析
• シーソー分析
• ポーターのファイブフォースモデル
  • サプライヤーパワー
  • バイヤーパワー
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係
• PESTEL分析
  • 政治情勢
  • 経済情勢
  • テクノロジーの情勢
  • 法的な情勢
  • 社会情勢

第5章 急性腎障害治療市場：治療方法別 2022-2032

• 市場概要
• 成長・収益分析：2023 vs 2032
• 市場セグメンテーション
  • 透析
  • 支持療法

第6章 急性腎障害治療市場：タイプ別 2022-2032

• 市場概要
• 成長・収益分析：2023 vs 2032
• 市場セグメンテーション
  • 腎前性急性腎障害
  • 内因性腎急性腎障害
  • 腎後急性腎障害

第7章 急性腎障害治療市場：エンドユーザー別 2022-2032

• 市場概要
• 成長・収益分析：2023 vs 2032
• 市場セグメンテーション
  • 病院
  • 外来手術センター
  • その他

第8章 北米の急性腎障害治療市場 2022-2032

• 市場概要
• 急性腎障害治療市場：治療方法別 2022-2032
• 急性腎障害治療市場：タイプ別 2022-2032
• 急性腎障害治療市場：エンドユーザー別 2022-2032
• 急性腎障害治療市場：地域別 2022-2032
  • 北米
    • 米国
    • カナダ
    • その他北米地域

第9章 英国と欧州連合の急性腎障害治療市場 2022-2032

• 市場概要
• 急性腎障害治療市場：治療方法別 2022-2032
• 急性腎障害治療市場：タイプ別 2022-2032
• 急性腎障害治療市場：エンドユーザー別 2022-2032
• 急性腎障害治療市場：地域別 2022-2032
  • 英国と欧州連合
    • 英国
    • ドイツ
    • スペイン
    • イタリア
    • フランス
    • その他欧州地域

第10章 アジア太平洋の急性腎障害治療市場 2022-2032

• 市場概要
• 急性腎障害治療市場：治療方法別 2022-2032
• 急性腎障害治療市場：タイプ別 2022-2032
• 急性腎障害治療市場：エンドユーザー別 2022-2032
• 急性腎障害治療市場：地域別 2022-2032
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域

第11章 ラテンアメリカの急性腎障害治療市場 2022-2032

• 市場概要
• 急性腎障害治療市場：治療方法別 2022-2032
• 急性腎障害治療市場：タイプ別 2022-2032
• 急性腎障害治療市場：エンドユーザー別 2022-2032
• 急性腎障害治療市場：地域別 2022-2032
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他ラテンアメリカ地域

第12章 中東・アフリカの急性腎障害治療市場 2022-2032

• 市場概要
• 急性腎障害治療市場：治療方法別 2022-2032
• 急性腎障害治療市場：タイプ別 2022-2032
• 急性腎障害治療市場：エンドユーザー別 2022-2032
• 急性腎障害治療市場：地域別 2022-2032
  • 中東・アフリカ
    • GCC
    • アフリカ
    • その他中東・アフリカ地域

第13章 企業プロファイル

• Fresenius Medical Care AG & Co. KGaA
• Baxter International Inc.
• B. Braun Melsungen AG
• Angion Biomedica Corp.
• AM-Pharma
• Quark Pharmaceuticals Inc.
• Asahi Kasei Medical Co. Ltd.
• LG Chem
• その他の主要企業

List of Tables

• TABLE 1 Global Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 2 Global Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 3 Global Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 4 North America Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 5 North America Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 6 North America Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 7 U.S. Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 8 U.S. Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 9 U.S. Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 10 Canada Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 11 Canada Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 12 Canada Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 13 Rest of North America Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 14 Rest of North America Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 15 Rest of North America Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 16 UK and European Union Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 17 UK and European Union Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 18 UK and European Union Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 19 UK Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 20 UK Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 21 UK Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 22 Germany Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 23 Germany Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 24 Germany Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 25 Spain Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 26 Spain Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 27 Spain Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 28 Italy Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 29 Italy Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 30 Italy Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 31 France Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 32 France Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 33 France Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 34 Rest of Europe Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 35 Rest of Europe Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 36 Rest of Europe Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 37 Asia Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 38 Asia Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 39 Asia Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 40 China Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 41 China Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 42 China Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 43 Japan Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 44 Japan Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 45 Japan Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 46 India Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 47 India Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 48 India Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 49 Australia Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 50 Australia Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 51 Australia Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 52 South Korea Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 53 South Korea Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 54 South Korea Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 55 Latin America Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 56 Latin America Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 57 Latin America Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 58 Brazil Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 59 Brazil Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 60 Brazil Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 61 Mexico Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 62 Mexico Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 63 Mexico Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 64 Rest of Latin America Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 65 Rest of Latin America Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 66 Rest of Latin America Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 67 Middle East and Africa Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 68 Middle East and Africa Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 69 Middle East and Africa Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 70 GCC Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 71 GCC Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 72 GCC Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 73 Africa Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 74 Africa Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 75 Africa Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)
• TABLE 76 Rest of Middle East and Africa Acute Kidney Injury Treatment Market By Treatment, 2022-2032, USD (Million)
• TABLE 77 Rest of Middle East and Africa Acute Kidney Injury Treatment Market By Type, 2022-2032, USD (Million)
• TABLE 78 Rest of Middle East and Africa Acute Kidney Injury Treatment Market By End-User, 2022-2032, USD (Million)

List of Figures

• FIG. 1 Global Acute Kidney Injury Treatment Market: Market Coverage
• FIG. 2 Research Methodology and Data Sources
• FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
• FIG. 4 Global Acute Kidney Injury Treatment Market: Quality Assurance
• FIG. 5 Global Acute Kidney Injury Treatment Market, By Treatment, 2023
• FIG. 6 Global Acute Kidney Injury Treatment Market, By Type, 2023
• FIG. 7 Global Acute Kidney Injury Treatment Market, By End-User, 2023
• FIG. 8 Global Acute Kidney Injury Treatment Market, By Geography, 2023
• FIG. 9 Market Geographical Opportunity Matrix - Global Acute Kidney Injury Treatment Market, 2023

FIG. 10Market Positioning of Key Acute Kidney Injury Treatment Market Players, 2023

FIG. 11Global Acute Kidney Injury Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032

• FIG. 12 Global Acute Kidney Injury Treatment Market, By Treatment, 2023 Vs 2032, %
• FIG. 13 Global Acute Kidney Injury Treatment Market, By Type, 2023 Vs 2032, %
• FIG. 14 Global Acute Kidney Injury Treatment Market, By End-User, 2023 Vs 2032, %
• FIG. 15 U.S. Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 16 Canada Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 17 Rest of North America Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 18 UK Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 19 Germany Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 20 Spain Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 21 Italy Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 22 France Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 23 Rest of Europe Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 24 China Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 25 Japan Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 26 India Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 27 Australia Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 28 South Korea Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 29 Rest of Asia Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 30 Brazil Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 31 Mexico Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 32 Rest of Latin America Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 33 GCC Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 34 Africa Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032
• FIG. 35 Rest of Middle East and Africa Acute Kidney Injury Treatment Market (US$ Million), 2022 - 2032

The acute kidney injury treatment market is expected to grow at a CAGR of 7.8% during the forecast period of 2024 to 2032, influenced by various drivers and segmented aspects. Three key drivers fuelling market growth include the increasing prevalence of acute kidney injury, advancements in treatment modalities, and a rising geriatric population. These factors contribute to a positive outlook for the market, with a forecasted surge in demand for effective AKI treatments. Competitive trends showcase the prowess of key players like Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., and B. Braun Melsungen AG. Their strategic initiatives, encompassing research and development, partnerships, and technological integration, underscore a vibrant and evolving market. These companies position themselves strategically to address challenges and capitalize on emerging opportunities, shaping the future trajectory of the Acute kidney injury treatment market.

Key Market Drivers

Advancements in Dialysis Technologies

The dialysis segment of the Acute kidney injury treatment market has experienced substantial growth, attributed to continuous advancements in dialysis technologies. In 2023, the market witnessed a surge in demand for more efficient and patient-friendly dialysis methods. Innovations such as wearable and portable dialysis devices gained traction, enhancing treatment accessibility and improving the quality of life for AKI patients. Evidence suggests a positive correlation between the adoption of advanced dialysis technologies and increased patient satisfaction.

Rising Focus on Supportive Care

Supportive care emerged as a pivotal driver in the Acute kidney injury treatment market, responding to the need for comprehensive patient management. The paradigm shifts towards holistic patient care, beyond traditional medical interventions, contributed to the prominence of supportive care. In 2023, evidence indicated a growing recognition of the importance of psychosocial support, nutritional interventions, and symptom management in improving AKI patient outcomes. Supportive care strategies demonstrated not only enhanced patient well-being but also potential cost-effectiveness.

Segmentation by AKI Type

Market segmentation based on AKI types, including Pre-renal AKI, Intrinsic Renal AKI, and Post-renal AKI, played a pivotal role in tailoring treatment approaches. In 2023, the highest revenue was observed in the Pre-renal AKI segment, reflecting the prevalence of conditions leading to reduced blood flow to the kidneys. Meanwhile, the Intrinsic Renal AKI segment exhibited the highest CAGR during the forecast period, signifying increasing recognition and targeted interventions for intrinsic kidney issues.

Challenges in Post-AKI Recovery

While advancements in acute treatment modalities are notable, the market faces a significant restraint concerning post-AKI recovery. In 2023, evidence pointed towards limited success in achieving complete recovery and preventing chronic kidney disease progression in some patients post-AKI. Despite acute treatment efficacy, the long-term impact and sustainable recovery remain areas of concern, posing challenges for both healthcare providers and patients.

Market by Treatment: Dialysis Dominate the Market

The market is primarily segmented into Dialysis and Supportive Care. In 2023, Dialysis emerged as the dominant treatment modality, capturing both the highest revenue and exhibiting the highest Compound Annual Growth Rate (CAGR) during the forecast period of 2024 to 2032. Dialysis, including hemodialysis and peritoneal dialysis, is instrumental in addressing the immediate complications associated with AKI, providing a crucial lifeline for patients.

Market by Type: Pre-renal AKI Segment Dominate the Market

AKI is classified into various types, including Pre-renal AKI, Intrinsic Renal AKI, and Post-renal AKI. The Pre-renal AKI segment commanded the highest revenue in 2023, indicating the prevalence of conditions leading to decreased blood flow to the kidneys, such as dehydration or heart failure. Concurrently, the Intrinsic Renal AKI segment exhibited the highest CAGR during the forecast period, highlighting the growing recognition and targeted interventions for intrinsic kidney issues, such as acute tubular necrosis.

Market by End-user: Hospitals Dominate the Market

End-user segmentation encompasses Hospitals, Ambulatory Surgical Centers (ASCs), and Other healthcare settings. Hospitals emerged as the leading end-user in 2023, both in terms of revenue and CAGR. The hospital setting is pivotal for managing acute cases of kidney injury, providing specialized care, and access to advanced treatment modalities. Ambulatory Surgical Centers and other healthcare facilities also play crucial roles in specific scenarios, contributing to the overall landscape of AKI treatment.

North America remains the Global Leader

The geographic segment analysis reveals compelling trends, reflecting regional variations in AKI prevalence, healthcare infrastructure, and treatment accessibility. Asia-Pacific demonstrated the highest CAGR in the Acute kidney injury treatment market. This growth is attributed to increased awareness, improved healthcare infrastructure, and a higher prevalence of conditions leading to AKI. The dynamic nature of this region's healthcare landscape positions it as a key player in the future trajectory of AKI treatment. In terms of revenue percentage, North America led the market in 2023. The dominance of this region is fueled by factors such as a large patient population, well-established healthcare facilities, and a proactive approach to AKI management. Understanding the regional nuances is crucial for stakeholders aiming to capitalize on emerging opportunities and address specific challenges in diverse healthcare ecosystems.

Market Competition to Intensify during the Forecast Period

In 2023, the Acute kidney injury treatment market witnessed prominent performances from key players, including Fresenius Medical Care AG & Co. KGaA, Baxter International Inc., B. Braun Melsungen AG, Angion Biomedica Corp., AM-Pharma, Quark Pharmaceuticals, Inc., Asahi Kasei Medical Co., Ltd., and LG Chem. These industry leaders strategically implemented initiatives such as research and development, partnerships, and geographical expansion to reinforce their market positions. Notably, Fresenius Medical Care AG & Co. KGaA emphasized cutting-edge technologies, while Baxter International Inc. focused on patient-centric approaches. Additionally, B. Braun Melsungen AG contributed significantly to market dynamics through strategic initiatives, including mergers and acquisitions and quality improvement. This highlights the vibrant and evolving competitive landscape in the Acute kidney injury treatment market.

Historical & Forecast Period

This study report represents analysis of each segment from 2022 to 2032 considering 2023 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2024 to 2032.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Acute Kidney Injury Treatment market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report

Micro and macro environment factors that are currently influencing the Acute Kidney Injury Treatment market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Treatment

• Dialysis

• Supportive Care

Type

• Pre-renal Acute Kidney Injury

• Intrinsic Renal Acute Kidney Injury

• Post-renal Acute Kidney Injury

End-User

• Hospitals

• Ambulatory Surgical Centers

• Others

Region Segment (2022-2032; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Acute Kidney Injury Treatment market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2032.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Acute Kidney Injury Treatment market?

Which is the largest regional market for Acute Kidney Injury Treatment market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Acute Kidney Injury Treatment market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Acute Kidney Injury Treatment market worldwide?

Table of Contents

1. Preface

• 1.1. Report Description
  • 1.1.1. Purpose of the Report
  • 1.1.2. Target Audience
  • 1.1.3. Key Offerings
• 1.2. Market Segmentation
• 1.3. Research Methodology
  • 1.3.1. Phase I - Secondary Research
  • 1.3.2. Phase II - Primary Research
  • 1.3.3. Phase III - Expert Panel Review
  • 1.3.4. Assumptions
  • 1.3.5. Approach Adopted

2. Executive Summary

• 2.1. Market Snapshot: Global Acute Kidney Injury Treatment Market
• 2.2. Global Acute Kidney Injury Treatment Market, By Treatment, 2023 (US$ Million)
• 2.3. Global Acute Kidney Injury Treatment Market, By Type, 2023 (US$ Million)
• 2.4. Global Acute Kidney Injury Treatment Market, By End-User, 2023 (US$ Million)
• 2.5. Global Acute Kidney Injury Treatment Market, By Geography, 2023 (US$ Million)
• 2.6. Attractive Investment Proposition by Geography, 2023

3. Acute Kidney Injury Treatment Market: Competitive Analysis

• 3.1. Market Positioning of Key Acute Kidney Injury Treatment Market Vendors
• 3.2. Strategies Adopted by Acute Kidney Injury Treatment Market Vendors
• 3.3. Key Industry Strategies
• 3.4. Tier Analysis 2023 Versus 2032

4. Acute Kidney Injury Treatment Market: Macro Analysis & Market Dynamics

• 4.1. Introduction
• 4.2. Global Acute Kidney Injury Treatment Market Value, 2022 - 2032, (US$ Million)
• 4.3. Market Dynamics
  • 4.3.1. Market Drivers
  • 4.3.2. Market Restraints
  • 4.3.3. Key Challenges
  • 4.3.4. Key Opportunities
• 4.4. Impact Analysis of Drivers and Restraints
• 4.5. See-Saw Analysis
• 4.6. Porter's Five Force Model
  • 4.6.1. Supplier Power
  • 4.6.2. Buyer Power
  • 4.6.3. Threat Of Substitutes
  • 4.6.4. Threat Of New Entrants
  • 4.6.5. Competitive Rivalry
• 4.7. PESTEL Analysis
  • 4.7.1. Political Landscape
  • 4.7.2. Economic Landscape
  • 4.7.3. Technology Landscape
  • 4.7.4. Legal Landscape
  • 4.7.5. Social Landscape

5. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)

• 5.1. Market Overview
• 5.2. Growth & Revenue Analysis: 2023 Versus 2032
• 5.3. Market Segmentation
  • 5.3.1. Dialysis
  • 5.3.2. Supportive Care

6. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)

• 6.1. Market Overview
• 6.2. Growth & Revenue Analysis: 2023 Versus 2032
• 6.3. Market Segmentation
  • 6.3.1. Pre-renal Acute Kidney Injury
  • 6.3.2. Intrinsic Renal Acute Kidney Injury
  • 6.3.3. Post-renal Acute Kidney Injury

7. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

• 7.1. Market Overview
• 7.2. Growth & Revenue Analysis: 2023 Versus 2032
• 7.3. Market Segmentation
  • 7.3.1. Hospitals
  • 7.3.2. Ambulatory Surgical Centers
  • 7.3.3. Others

8. North America Acute Kidney Injury Treatment Market, 2022-2032, USD (Million)

• 8.1. Market Overview
• 8.2. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
• 8.3. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
• 8.4. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
• 8.5.Acute Kidney Injury Treatment Market: By Region, 2022-2032, USD (Million)
  • 8.5.1.North America
    • 8.5.1.1. U.S.
      • 8.5.1.1.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 8.5.1.1.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 8.5.1.1.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 8.5.1.2. Canada
      • 8.5.1.2.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 8.5.1.2.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 8.5.1.2.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 8.5.1.3. Rest of North America
      • 8.5.1.3.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 8.5.1.3.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 8.5.1.3.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

9. UK and European Union Acute Kidney Injury Treatment Market, 2022-2032, USD (Million)

• 9.1. Market Overview
• 9.2. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
• 9.3. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
• 9.4. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
• 9.5.Acute Kidney Injury Treatment Market: By Region, 2022-2032, USD (Million)
  • 9.5.1.UK and European Union
    • 9.5.1.1. UK
      • 9.5.1.1.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 9.5.1.1.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 9.5.1.1.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 9.5.1.2. Germany
      • 9.5.1.2.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 9.5.1.2.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 9.5.1.2.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 9.5.1.3. Spain
      • 9.5.1.3.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 9.5.1.3.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 9.5.1.3.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 9.5.1.4. Italy
      • 9.5.1.4.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 9.5.1.4.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 9.5.1.4.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 9.5.1.5. France
      • 9.5.1.5.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 9.5.1.5.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 9.5.1.5.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 9.5.1.6. Rest of Europe
      • 9.5.1.6.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 9.5.1.6.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 9.5.1.6.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

10. Asia Pacific Acute Kidney Injury Treatment Market, 2022-2032, USD (Million)

• 10.1. Market Overview
• 10.2. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
• 10.3. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
• 10.4. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
• 10.5.Acute Kidney Injury Treatment Market: By Region, 2022-2032, USD (Million)
  • 10.5.1.Asia Pacific
    • 10.5.1.1. China
      • 10.5.1.1.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 10.5.1.1.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 10.5.1.1.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 10.5.1.2. Japan
      • 10.5.1.2.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 10.5.1.2.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 10.5.1.2.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 10.5.1.3. India
      • 10.5.1.3.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 10.5.1.3.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 10.5.1.3.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 10.5.1.4. Australia
      • 10.5.1.4.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 10.5.1.4.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 10.5.1.4.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 10.5.1.5. South Korea
      • 10.5.1.5.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 10.5.1.5.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 10.5.1.5.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 10.5.1.6. Rest of Asia Pacific
      • 10.5.1.6.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 10.5.1.6.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 10.5.1.6.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

11. Latin America Acute Kidney Injury Treatment Market, 2022-2032, USD (Million)

• 11.1. Market Overview
• 11.2. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
• 11.3. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
• 11.4. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
• 11.5.Acute Kidney Injury Treatment Market: By Region, 2022-2032, USD (Million)
  • 11.5.1.Latin America
    • 11.5.1.1. Brazil
      • 11.5.1.1.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 11.5.1.1.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 11.5.1.1.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 11.5.1.2. Mexico
      • 11.5.1.2.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 11.5.1.2.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 11.5.1.2.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 11.5.1.3. Rest of Latin America
      • 11.5.1.3.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 11.5.1.3.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 11.5.1.3.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

12. Middle East and Africa Acute Kidney Injury Treatment Market, 2022-2032, USD (Million)

• 12.1. Market Overview
• 12.2. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
• 12.3. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
• 12.4. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
• 12.5.Acute Kidney Injury Treatment Market: By Region, 2022-2032, USD (Million)
  • 12.5.1.Middle East and Africa
    • 12.5.1.1. GCC
      • 12.5.1.1.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 12.5.1.1.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 12.5.1.1.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 12.5.1.2. Africa
      • 12.5.1.2.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 12.5.1.2.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 12.5.1.2.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)
    • 12.5.1.3. Rest of Middle East and Africa
      • 12.5.1.3.1. Acute Kidney Injury Treatment Market: By Treatment, 2022-2032, USD (Million)
      • 12.5.1.3.2. Acute Kidney Injury Treatment Market: By Type, 2022-2032, USD (Million)
      • 12.5.1.3.3. Acute Kidney Injury Treatment Market: By End-User, 2022-2032, USD (Million)

13. Company Profile

• 13.1. Fresenius Medical Care AG & Co. KGaA
  • 13.1.1. Company Overview
  • 13.1.2. Financial Performance
  • 13.1.3. Product Portfolio
  • 13.1.4. Strategic Initiatives
• 13.2. Baxter International Inc.
  • 13.2.1. Company Overview
  • 13.2.2. Financial Performance
  • 13.2.3. Product Portfolio
  • 13.2.4. Strategic Initiatives
• 13.3. B. Braun Melsungen AG
  • 13.3.1. Company Overview
  • 13.3.2. Financial Performance
  • 13.3.3. Product Portfolio
  • 13.3.4. Strategic Initiatives
• 13.4. Angion Biomedica Corp.
  • 13.4.1. Company Overview
  • 13.4.2. Financial Performance
  • 13.4.3. Product Portfolio
  • 13.4.4. Strategic Initiatives
• 13.5. AM-Pharma
  • 13.5.1. Company Overview
  • 13.5.2. Financial Performance
  • 13.5.3. Product Portfolio
  • 13.5.4. Strategic Initiatives
• 13.6. Quark Pharmaceuticals, Inc.
  • 13.6.1. Company Overview
  • 13.6.2. Financial Performance
  • 13.6.3. Product Portfolio
  • 13.6.4. Strategic Initiatives
• 13.7. Asahi Kasei Medical Co., Ltd.
  • 13.7.1. Company Overview
  • 13.7.2. Financial Performance
  • 13.7.3. Product Portfolio
  • 13.7.4. Strategic Initiatives
• 13.8. LG Chem
  • 13.8.1. Company Overview
  • 13.8.2. Financial Performance
  • 13.8.3. Product Portfolio
  • 13.8.4. Strategic Initiatives
• 13.9. Other Notable Players
  • 13.9.1. Company Overview
  • 13.9.2. Financial Performance
  • 13.9.3. Product Portfolio
  • 13.9.4. Strategic Initiatives